文献速递肾移植

美国肾移植候选者接受 deceased donor 移植预后不良的决策工具

A tool for decision-making in kidney transplant candidates with poor prognosis to receive deceased donor transplantation in the United States.
PubMed 文献 · Kidney Int · 2022-06-26

该研究回顾性分析美国2014年肾脏分配系统后208,717例成人肾移植候选者的国家登记数据,采用竞争风险模型评估 deceased donor 移植(DDTX)与死亡或退出等待名单的等效风险时间(TiTER)。结果显示部分候选者(尤其老年、糖尿病、B型或O型血及透析时间短者)随等待时间延长死亡或退出风险超过DDTX,TiTER可用于共享决策。

要点

  • 65-69岁候选者DDTX的TiTER平均41个月,70岁及以上为28个月。
  • 39.6%候选者所在风险组TiTER低于72个月,18.5%低于24个月。
  • 老年候选者接受年轻供者或低KDPI肾脏时TiTER显著缩短。

核心结论

  • 美国大量等待名单患者接受DDTX的预后不良,TiTER可能有助于共享决策并量化接受相对高风险供器官的获益。

研究设计与样本

  • 回顾性分析美国国家移植受者科学登记系统(SRTR)数据,纳入2014年肾脏分配系统后的208,717例成人肾移植候选者,采用竞争风险模型评估TiTER。

主要发现

  • 所有组别中,DDTX的累积发生率从登记时起初始高于死亡或退出等待名单。
  • 随等待时间延长,部分患者组(尤其老年、糖尿病、B型或O型血及透析时间短者)死亡或退出等待名单的累积发生率超过DDTX。
  • 65-69岁候选者DDTX的TiTER平均41个月,70岁及以上为28个月。
  • 39.6%候选者所在风险组TiTER低于72个月,18.5%低于24个月。
  • 老年候选者接受年轻供者或低KDPI肾脏时TiTER显著缩短。

关键数值与推荐

  • TiTER定义为DDTX与死亡或退出等待名单的等效风险时间。
  • 按肾脏供者风险指数(KDPI)和供者年龄评估TiTER。

临床怎么用

  • 作者认为TiTER可能是传播和量化接受相对高风险供器官获益的有用工具,可改善等待名单登记时的共享决策。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The primary outcomes for kidney transplant candidates are receipt of deceased or living donor transplant, death or removal from the waiting list. Here, we conducted a retrospective analysis of national Scientific Registry of Transplant Recipients data to evaluate outcomes for 208,717 adult kidney transplant candidates following the 2014 Kidney Allocation System in the United States. Competing risks models were utilized to evaluate Time to Equivalent Risk (TiTER) of deceased donor transplantation (DDTX) and death versus waitlist removal. We also evaluated TiTER based on kidney donor profile index (KDPI) and donor age. For all groups, the cumulative incidence of DDTX was initially higher from time of listing than death or waitlist removal. However, following accrued time on the waiting list, the cumulative incidence of death or waitlist removal exceeded DDTX for certain patient groups, particularly older, diabetic, blood type B and O and shorter pre-listing dialysis time. TiTER for all candidates aged 65-69 averaged 41 months and for 70 and older patients 28 months. Overall, 39.6% of candidates were in risk groups with TiTER under 72 months and 18.5% in groups with TiTER under 24 months. Particularly for older candidates, TiTER for kidneys was substantially shorter for younger donors or lower KDPI. Thus, our findings reveal that a large proportion of wait-listed patients in the United States have poor prognoses to ever undergo DDTX and our data may improve shared decision-making for candidates at time of waitlist placement. Hence, for specific patient groups, TiTER may be a useful tool to disseminate and quantify benefits of accepting relatively high risk donor organs.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Schold JD, Huml AM, Poggio ED, et al. A tool for decision-making in kidney transplant candidates with poor prognosis to receive deceased donor transplantation in the United States. Kidney Int. 2022. PMID: 35760150. doi:10.1016/j.kint.2022.05.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。